Drugs & Targets Amgen and McKesson collaborate to advance cancer innovation in communities December 11, 2020Vol.46 No.46
Drugs & Targets Danyelza receives FDA approval for treatment of neuroblastoma December 04, 2020Vol.46 No.45
Drugs & Targets Gavreto receives FDA approval for RET-altered thyroid cancers December 04, 2020Vol.46 No.45
Drugs & Targets FDA approves first PSMA-targeted PET imaging drug for in prostate cancer December 04, 2020Vol.46 No.45
Drugs & Targets European Commission approves Opdivo as second-line treatment for unresectable advanced, recurrent or metastatic ESCC December 04, 2020Vol.46 No.45
Drugs & Targets EMA validates tepotinib application for treatment of advanced NSCLC with METex14 skipping alterations December 04, 2020Vol.46 No.45
Drugs & TargetsFree Keytruda receives accelerated approval from FDA for locally recurrent, unresectable or metastatic TNBC November 20, 2020Vol.46 No.44
Drugs & TargetsFree FDA issues draft guidance to provide important considerations in cross labeling of oncology drugs November 20, 2020Vol.46 No.44
Drugs & TargetsFree CDER and CBER to increase Emergency Use Authorization transparency November 20, 2020Vol.46 No.44
Drugs & TargetsFree Agendia and Paige collaborate on breast cancer research November 20, 2020Vol.46 No.44
